Research programme: 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors - vTv Therapeutics

Drug Profile

Research programme: 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors - vTv Therapeutics

Alternative Names: HPP 851

Latest Information Update: 27 Jan 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novo Nordisk
  • Developer TransTech Pharma; vTv Therapeutics LLC
  • Class Small molecules
  • Mechanism of Action 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Glaucoma; Metabolic disorders

Most Recent Events

  • 27 Jan 2016 Discontinued - Preclinical for Glaucoma in USA (Ophthalmic)
  • 21 Sep 2010 Discontinued - Preclinical for Metabolic disorders in USA (unspecified route)
  • 26 Jan 2008 Preclinical trials in Metabolic disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top